Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · AMRUTANJAN

AMRUTANJAN

HealthcarePharmaceuticals & Biotechnology₹1492 cr market cap
₹514.40 ▼ -0.39% today As of 19 Nov 2026
52-week low ₹487.6552-week high ₹719.85

-28.3% from the 52-week high · +5.9% above the low

Amrutanjan Health Care Ltd. engages in the manufacture and sale of ayurvedic and allopathic products. The company is headquartered in Chennai, Tamil Nadu and currently employs 647 full-time employees. The company went IPO on 2009-11-05. Its segments include OTC Products, Beverages and Others. The OTC Products segment is engaged in manufacturing products of pain management, congestion management and hygiene. The Beverages segment is engaged in manufacturing fruit juices and oral hydration drinks. The Others segment includes the pain management center. Its pain management products include Pain Balm Extra Power, Strong Pain Balm, New Maha Strong Pain Balm, Roll on and Advanced Back Pain + Roll-On, among others. Its congestion management products include Relief Cold Rub, Relief Nasal Inhaler, Relief Cough Syrup and Relief Swas Mint. Its women's hygiene products include Comfy Snug Fit, Comfy Snug Fit XL and Comfy Snug Fit ULTRA XL. Its beverages include Fruitnik and Fruitnik Electro+. The company also has other products category.

The short version. Promoter holding was 46.52% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

AMRUTANJAN trades 28.3% below its 52-week high and 5.9% above its 52-week low.

Change over period: —

1M+3.5%
3M+3.5%
6M-6.2%
1Y-26.8%

4 · The owners

Who holds it, and are they adding?

Promoter holding46.52%

Unchanged over 8 quarters.

Foreign institutions3.47%

Up 1.17 pts over 8 quarters.

Domestic institutions6.9%

Down 4.22 pts over 8 quarters.

Mutual fund schemes7

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter46.5246.5246.5246.5246.5246.5246.5246.520.0
FII2.32.32.412.382.272.172.443.47+1.17
DII11.1211.4112.712.913.012.6612.286.9-4.22
Public40.0239.7438.3338.1638.1838.6138.7243.08+3.06

Mutual fund holdings · Oct 2026

7 schemes hold this stock

7 the month before.

  • ICICI Prudential FMCG Fund2.16% of NAV
  • ICICI Prudential Quant Fund1.39% of NAV
  • ICICI Prudential Balanced Hybrid Fund1.2% of NAV
  • ICICI Prudential Conservative Hybrid Fund0.1% of NAV
  • Motilal Oswal BSE Healthcare ETF0.05% of NAV
  • Bandhan BSE Healthcare Index Fund0.05% of NAV
  • DSP Small Cap Fund0.01% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for AMRUTANJAN are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about AMRUTANJAN

What is the AMRUTANJAN share price?

AMRUTANJAN (AMRUTANJAN) last closed at ₹514.40, down 0.39% on the day. Its 52-week range is ₹487.65 to ₹719.85.

What is the market cap of AMRUTANJAN?

AMRUTANJAN has a market capitalisation of about ₹1,492 crore. Its price-to-earnings ratio is 25.9.

How are AMRUTANJAN's latest results?

Promoter holding was 46.52% in Sep 2026, up 0.00 points over 8 quarters.

Who owns AMRUTANJAN?

As of Sep 2026, shareholding was: Promoter 46.52%, FII 3.47%, DII 6.9%, Public 43.08%.

How many mutual funds hold AMRUTANJAN?

7 mutual fund schemes held AMRUTANJAN in October 2026. That compares with 7 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 06 Feb 2026 · Interim Dividend - Rs. 1
  • 18 Nov 2025 · Interim Dividend - Rs. 1
  • 16 Sep 2025 · Final Dividend - Rs. 2.6
  • 18 Feb 2025 · Interim Dividend - Rs. 1
  • 22 Nov 2024 · Interim Dividend - Rs. 1
  • 13 Sep 2024 · Final Dividend - Rs. 2.6

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.